Protagenic Therapeutics financial indicator trend analysis is much more than just breaking down Protagenic Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagenic Therapeutics is a good investment. Please check the relationship between Protagenic Therapeutics Non Current Assets Total and its Short Term Investments accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
The correlation between Protagenic Therapeutics' Non Current Assets Total and Short Term Investments is 0.09. Overlapping area represents the amount of variation of Non Current Assets Total that can explain the historical movement of Short Term Investments in the same time period over historical financial statements of Protagenic Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagenic Therapeutics' Non Current Assets Total and Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Assets Total of Protagenic Therapeutics are associated (or correlated) with its Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Investments has no effect on the direction of Non Current Assets Total i.e., Protagenic Therapeutics' Non Current Assets Total and Short Term Investments go up and down completely randomly.
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Short Term Investments
Short Term Investments is an item under the current assets section of Protagenic Therapeutics balance sheet. It contains any investments Protagenic Therapeutics undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Protagenic Therapeutics can easily liquidate in the marketplace.
Most indicators from Protagenic Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagenic Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagenic Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.